Search Results - "Heibel, B."

  • Showing 1 - 7 results of 7
Refine Results
  1. 1

    Time to Optimize Supplementation: Modifying Factors Influencing the Individual Responses to Extracellular Buffering Agents by Heibel, André B, Perim, Pedro H L, Oliveira, Luana F, McNaughton, Lars R, Saunders, Bryan

    Published in Frontiers in nutrition (Lausanne) (08-05-2018)
    “…Blood alkalosis, as indicated by an increased blood bicarbonate concentration and pH, has been shown to be beneficial for exercise performance. Sodium…”
    Get full text
    Journal Article
  2. 2

    Effect of food on the pharmacokinetics of the active metabolite of the prodrug repirinast by Schaefer, H G, Beermann, D, Horstmann, R, Wargenau, M, Heibel, B A, Kuhlmann, J

    Published in Journal of pharmaceutical sciences (01-01-1993)
    “…The effect of food on the pharmacokinetics of the active metabolite of the new antiasthmatic drug repirinast was investigated in two different studies after…”
    Get more information
    Journal Article
  3. 3

    Pharmacokinetics of the active metabolite of the prodrug repirinast in healthy Caucasian volunteers after a single oral dose by BEERMANN, D, SCHAEFER, H. G, WARGENAU, M, HEIBEL, B, STURM, Y, KUHLMANN, J

    Published in European journal of clinical pharmacology (01-03-1992)
    “…The pharmacokinetics of BAY w 8199, the active metabolite of the prodrug repirinast (BAY u 2372), has been investigated after oral administration of 150, 300…”
    Get full text
    Journal Article
  4. 4

    Clinical pharmacology of the hypocholesterolemic agent K 12.148 (lifibrol) in healthy volunteers by HSASIBEDER, H, STAAB, H. J, SEIBEL, K, HEIBEL, B, SCHMIDLE, G, MAÊRZ, W

    “…K 12.148 (INN:lifibrol), a new cholesterol synthesis inhibitor, was studied in healthy volunteers to evaluate tolerance/safety, the effects on lipids, and…”
    Get full text
    Conference Proceeding Journal Article
  5. 5

    Subjective symptoms and pharmacokinetics/dynamics of metoprolol CR in elderly subjects : a comparison with atenolol by DIMENÄS, E. S, DAHLOÊF, C. G, HEIBEL, B, MOORE, R. G, OLOFSSON, B. K, WESTERGREN, G. E, LUÊCKER, P. W

    Published in European journal of clinical pharmacology (01-01-1990)
    “…In a double-blind, randomised, cross-over study, the pharmacokinetic/dynamic effects and subjective symptoms of a new controlled-release (CR) formulation of…”
    Get full text
    Journal Article
  6. 6

    Bioequivalence of two atenolol formulations in healthy volunteers. Evaluation and prediction of effect kinetics at beta-adrenoceptors in vivo by means of a radioreceptor assay by Sitzler, G, Heibel, B, Lücker, P W, Palm, D

    “…Pharmacokinetic and pharmacodynamic effects of single oral doses of 200 mg of two atenolol formulations (Tenormin, atenolol (T) and Duraatenolol, atenolol (D))…”
    Get more information
    Journal Article
  7. 7